Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
6.42
+0.12 (1.90%)
At close: Jul 31, 2026, 4:00 PM EDT
6.45
+0.03 (0.47%)
After-hours: Jul 31, 2026, 4:54 PM EDT

Achieve Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-52.06-54.88-39.07-27.25-40.8-33.09
Net Income
-51.99-54.65-39.83-29.82-42.35-33.15
Earnings Per Share
-1.12-1.25-1.24-1.50-4.00-4.08
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.2736.434.3615.5524.7743.02
Total Debt
14.9514.959.8916.7316.214.99
Net Cash (Debt)
14.3221.4524.47-1.198.5728.03
Net Cash Growth
7.77%-12.32%---69.41%-21.45%
Net Cash Per Share
0.300.490.76-0.060.813.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-45.31-49.47-29.77-24.48-37.57-29.44
Capital Expenditures
--0--0.02--
Free Cash Flow
-45.31-49.47-29.77-24.5-37.57-29.44
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.